Expert Opinion on Drug Discovery, Volume 16, Issue 10 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Discovery, Volume 16, Issue 10 (2021)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Volume 16, 2021 Vol 15, 2020 Vol 14, 2019 Vol 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
How can we accelerate COVID-19 vaccine discovery?
Giulia Russo, Valentina Di Salvatore, Filippo Caraci, Cristina Curreli, Marco Viceconti & Francesco Pappalardo
Pages: 1081-1084
Published online: 08 Jun 2021
First Page PreviewforHow can we accelerate COVID-19 vaccine discovery? | Full Text | References | PDF (1.1 MB) | EPUB
  • 2148 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery
Heribert Playa-Albinyana, Fabian Arenas & Dolors Colomer
Pages: 1085-1090
Published online: 11 Jun 2021
First Page PreviewforAdvantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery | Full Text | References | PDF (4.8 MB) | EPUB
  • 3960 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Discovery Case History

Article
The pre-clinical discovery and development of osimertinib used to treat non-small cell lung cancer
Florian Wittlinger & Stefan A. Laufer
Pages: 1091-1103
Published online: 20 Jun 2021
AbstractforThe pre-clinical discovery and development of osimertinib used to treat non-small cell lung cancer | Full Text | References | PDF (646.2 KB) | EPUB
  • 444 Views
  • 4 CrossRef citations
  • 0Altmetric

Review

Approaches for refining and furthering the development of CAR-based T cell therapies for solid malignancies
Caroline M Hull & John Maher
Pages: 1105-1117
Published online: 26 May 2021
AbstractforApproaches for refining and furthering the development of CAR-based T cell therapies for solid malignancies | Full Text | References | PDF (822.9 KB) | EPUB
  • 2417 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design
Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, Subhash Chander, Selvaraj Kunjiappan & Sankaranarayanan Murugesan
Pages: 1119-1147
Published online: 28 Apr 2021
Abstractfor1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design | Full Text | References | PDF (6.8 MB) | EPUB
  • 348 Views
  • 12 CrossRef citations
  • 0Altmetric
An overview of ProTide technology and its implications to drug discovery
Michaela Serpi & Fabrizio Pertusati
Pages: 1149-1161
Published online: 24 May 2021
AbstractforAn overview of ProTide technology and its implications to drug discovery | Full Text | References | PDF (982.1 KB) | EPUB
  • 678 Views
  • 11 CrossRef citations
  • 0Altmetric
Advances in venom peptide drug discovery: where are we at and where are we heading?
Taylor B. Smallwood & Richard J. Clark
Pages: 1163-1173
Published online: 24 May 2021
AbstractforAdvances in venom peptide drug discovery: where are we at and where are we heading? | Full Text | References | PDF (1.8 MB) | EPUB
  • 679 Views
  • 7 CrossRef citations
  • 0Altmetric
Computational representations of protein–ligand interfaces for structure-based virtual screening
Tong Qin, Zihao Zhu, Xiang Simon Wang, Jie Xia & Song Wu
Pages: 1175-1192
Published online: 03 Jun 2021
AbstractforComputational representations of protein–ligand interfaces for structure-based virtual screening | Full Text | References | PDF (1.9 MB) | EPUB
  • 643 Views
  • 7 CrossRef citations
  • 0Altmetric
The identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease
Stefano Fiorucci, Michele Biagioli, Monia Baldoni, Patrizia Ricci, Valentina Sepe, Angela Zampella & Eleonora Distrutti
Pages: 1193-1208
Published online: 05 May 2021
AbstractforThe identification of farnesoid X receptor modulators as treatment options for nonalcoholic fatty liver disease | Full Text | References | PDF (521.2 KB) | EPUB
  • 382 Views
  • 11 CrossRef citations
  • 0Altmetric
Advances in the discovery of novel agents for the treatment of glaucoma
Francesco Mincione, Alessio Nocentini & Claudiu T. Supuran
Pages: 1209-1225
Published online: 18 May 2021
AbstractforAdvances in the discovery of novel agents for the treatment of glaucoma | Full Text | References | PDF (1.9 MB) | EPUB
  • 342 Views
  • 15 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The value of protein allostery in rational anticancer drug design: an update
Ruth Nussinov et al.
Review Article | Published online: 28 Jul 2024
Open Access
Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies
Imane Charmarke-Askar et al.
Review Article | Published online: 22 Jul 2024
What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
View all latest articles